Submitted by Anonymous (not verified) on 18 August 2026 - 12:37
Human medicines European public assessment report (EPAR): Conexxence, denosumab, Date of authorisation: 18/07/2025, Revision: 2, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Conexxence, denosumab, Date of authorisation: 18/07/2025, Revision: 2, Status: Authorised